Emilie C H Breekveldt

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 14, 2024
Platinum retention in plasma, urine, and normal colonic mucosa in cisplatin-treated testicular cancer survivors.

Emilie C H Breekveldt, Berbel L M Ykema, Alwin D R Huitema

|Dec 27, 2023
Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy.

Emilie C H Breekveldt, Berbel L M Ykema, Tanya M Bisseling

|Nov 29, 2022
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.

Emilie C H Breekveldt, Esther Toes-Zoutendijk, Hilliene J van de Schootbrugge-Vandermeer

|Jun 24, 2022
Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.

Lucie de Jonge, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt

|May 10, 2022
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.

Reinier G S Meester, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt

Pageof 1